Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Updates in Surgery
Erschienen in: Updates in Surgery 4/2021

14.08.2021 | Review Article

Contemporary indications for upfront total pancreatectomy

verfasst von: Riccardo Casadei, Claudio Ricci, Carlo Ingaldi, Laura Alberici, Francesco Minni

Erschienen in: Updates in Surgery | Ausgabe 4/2021

Einloggen, um Zugang zu erhalten

Abstract

Currently, advances in surgical techniques, improvements in perioperative care, new formulations of intermediate and long-acting insulin and of modern pancreatic enzyme preparations have allowed obtaining good short and long-term results and quality of life, especially in high-volume centres in performing total pancreatectomy (TP).Thus, the surgeon’s fear in performing TP is not justified and total pancreatectomy can be considered a viable option in selected patients in high-volume centres. The aim of this review was to define the current indications for this procedure, in particular for upfront TP, considering not only the pancreatic disease, but also the surgical approach (open, mini-invasive) and the relationship with vascular resection.
Literatur
1.
2.
3.
Yeo CJ, Cameron JL, Lillemoe KD et al (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas. Ann Surg 221:721–771PubMedPubMedCentral
4.
Ross DE (1954) Cancer of the pancreas; a plea for total pancreatectomy. Am J Surg 87:20–33PubMed
5.
Müller MW, Friess H, Kleeff J et al (2007) Is there still a role for total pancreatectomy? Ann Surg 246:966–975PubMed
6.
Fujino Y, Matsumoto I, Ajiki T et al (2009) Clinical reappraisal of total pancreatectomy for pancreatic disease. Hepatogastroenterology 56:1525–1528PubMed
7.
8.
Casadei R, Monari F, Buscemi S et al (2010) Total pancreatectomy: indications, operative technique, and results: a single centre experience and review of literature. Updates Surg 62:41–46PubMed
9.
Parsaik AK, Murad MH, Sathananthan A et al (2010) Metabolic and target organ outcomes after total pancreatectomy: Mayo Clinic experience and meta-analysis of the literature. Clin Endocrinol 73:723–731
10.
Crippa S, Tamburrino D, Partelli S et al (2011) Total pancreatectomy: indications, different timing, and perioperative and long-term outcomes. Surgery 149:79–86PubMed
11.
Barbier L, Jamal W, Dokmak S et al (2013) Impact of total pancreatectomy: short-and long-term assessment. HPB (Oxford) 15:882–892
12.
Epelboym I, Winner M, DiNorcia J et al (2014) Quality of life in patients after total pancreatectomy is comparable with quality of life in patients who undergo a partial pancreatic resection. J Surg Res 187:189–196PubMed
13.
Takami H, Fujii T, Kanda M et al (2014) Preservation of the pyloric ring confers little benefit in patients undergoing total pancreatectomy. World J Surg 38:1807–1813PubMed
14.
Hartwig W, Gluth A, Hinz U et al (2015) Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation. Ann Surg 261:537–546PubMed
15.
Watanabe Y, Ohtsuka T, Matsunaga T et al (2015) Long-term outcomes after total pancreatectomy: special reference to survivors’ living conditions and quality of life. World J Surg 39:1231–1239PubMed
16.
Casadei R, Ricci C, Taffurelli G et al (2016) Is total pancreatectomy as feasible, safe, efficacious, and cost-effective as pancreaticoduodenectomy? A single centre, prospective, observational study. J Gastrointest Surg 20:1595–1607PubMed
17.
Hata T, Ishida M, Motoi F et al (2016) Clinical characteristics and risk factors for the development of postoperative hepatic steatosis after total pancreatectomy. Pancreas 45:362–369PubMed
18.
Suzuki S, Miura J, Shimizu K et al (2016) Clinico physiological outcomes after total pancreatectomy. Scand J Gastroenterol 51:1526–1531PubMed
19.
Zakaria HM, Stauffer JA, Raimondo M et al (2016) Total pancreatectomy: short- and long-term outcomes at a high-volume pancreas centre. World J Gastrointest Surg 8:634–642PubMedPubMedCentral
20.
Shi HJ, Jin C, Fu DL (2017) Impact of postoperative glycemic control and nutritional status on clinical outcomes after total pancreatectomy. World J Gastroenterol 23:265–274PubMedPubMedCentral
21.
Pulvirenti A, Pea A, Rezaee N et al (2019) Perioperative outcomes and long-term quality of life after total pancreatectomy. Br J Surg 106:1819–1828PubMed
22.
Maeda S, Ariake K, Iseki M et al (2020) Prognostic indicators in pancreatic cancer patients undergoing total pancreatectomy. Surg Today 50:490–498PubMed
23.
Petrucciani N, Nigri G, Giannini G et al (2020) Total pancreatectomy for pancreatic carcinoma: when, why, and what are the outcomes? Results of a systematic review. Pancreas 49:175–180PubMed
24.
Andrén-Sandberg Å, Ansorge C, Yadav TD (2016) Are there indications for total pancreatectomy in 2016? Dig Surg 33:329–334PubMed
25.
26.
Scholten L, Stoop TF, Del Chiaro M et al (2019) Systematic review of functional outcome and quality of life after total pancreatectomy. Br J Surg 106:1735–1746PubMedPubMedCentral
27.
Reddy S, Wolfgang CL, Cameron JL et al (2009) Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term Survival. Ann Surg 250:282–287PubMed
28.
Nathan H, Wolfgang CL, Edil BH et al (2009) Peri-operative mortality and long-term survival after total pancreatectomy for pancreatic adenocarcinoma: a population-based perspective. J Surg Oncol 99:87–92PubMed
29.
Stoop TF, Ateeb Z, Ghorbani P et al (2021) Surgical outcomes after total pancreatectomy: a high-volume centre experience. Ann Surg Oncol 28:1543–1551PubMed
30.
31.
32.
Johnston WC, Hoen HM, Cassera MA et al (2016) Total pancreatectomy for pancreatic ductal adenocarcinoma: review of the National Cancer Data Base. HPB 18:21–28PubMed
33.
Almond M, Rob KJ, Hodson J et al (2015) Changing indications for a total pancreatectomy: perspectives over a quarter of a century. HPB (Oxford) 17:416–421
34.
Bhayani NH, Miller JL, Ortenzi G et al (2014) Perioperative outcomes of pancreaticoduodenectomy compared to total pancreatectomy for neoplasia. J Gastrointest Surg 18:549–554PubMed
35.
Satoi S, Murakami Y, Motoi F et al (2015) Reappraisal of peritoneal washing cytology in 984 patients with pancreatic ductal adenocarcinoma who underwent margin-negative resection. J Gastrointest Surg 19:6–14PubMed
36.
Yang DJ, Xiong JJ, Liu XT et al (2019) Total pancreatectomy compared with pancreaticoduodenectomy: a systematic review and meta-analysis. Cancer Manag Res 11:3899–3908PubMedPubMedCentral
37.
Luu AM, Olchanetski B, Herzog T et al (2021) Is primary total pancreatectomy in patients with high-risk pancreatic remnant justified and preferable to pancreaticoduodenectomy? a matched-pairs analysis of 200 patients. Gland Surg 10:618–628PubMedPubMedCentral
38.
Sauvanet A (2008) Intraductal papillary mucinous neoplasms of the pancreas: indication, extent, and results of surgery. Surg Oncol Clin N Am 17:587–606PubMed
39.
Bilimoria KY, Talamonti MS, Tomlinson JS et al (2008) Prognostic score predicting survival after resection of pancreatic neuroendocrine tumours: analysis of 3851 patients. Ann Surg 247:490–500PubMed
40.
Zerbi A, Ortolano E, Balzano G et al (2008) Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection? Ann Surg Oncol 15:1161–1168PubMed
41.
Karpoff HM, Klimstra DS, Brennan MF et al (2001) Results of total pancreatectomy for adenocarcinoma of the pancreas. Arch Surg 136:44–47PubMed
42.
McPhee JT, Hill JS, Whalen GF et al (2007) Perioperative mortality for pancreatectomy: a national perspective. Ann Surg 246:246–253PubMedPubMedCentral
43.
Wang X, Li Y, Cai Y et al (2017) Laparoscopic total pancreatectomy: case report and literature review. Medicine (Baltimore) 96:e5869
44.
45.
46.
Petrucciani N, Nigri G, Debs T et al (2016) Frozen section analysis of the pancreatic margin during pancreaticoduodenectomy for cancer: does extending the resection to obtain a secondary R0 provide a survival benefit? Results of a systematic review. Pancreatology 16:1037–1043PubMed
47.
Crippa S, Guarneri G, Belfiori G et al (2020) Positive neck margin at frozen section analysis is a significant predictor of tumour recurrence and poor survival after pancreatodudenectomy for pancreatic cancer. Eur J Surg Oncol 46:1524–1531PubMed
48.
Crippa S, Ricci C, Guarneri G et al (2021) Improved survival after pancreatic re-resection of positive neck margin in pancreatic cancer patients. A systematic review and network meta-analysis. Eur J Surg Oncol 47:1258–1266PubMed
49.
Venkat R, Puhan MA, Schulick RD et al (2011) Predicting the risk of perioperative mortality in patients undergoing pancreaticoduodenectomy: a novel scoring system. Arch Surg 146:1277–1284PubMed
50.
Hashimoto D, Mizuma M, Kumamaru H et al (2020) Risk model for severe postoperative complications after total pancreatectomy based on a nationwide clinical database. BJS 107:734–742
51.
Del Chiaro M, Segersvärd R, Rangelova E et al (2015) Cattell-Braasch Maneuver combined with artery-first approach for superior mesenteric-portal vein resection during pancreatectomy. J Gastrointest Surg 19:2264–2268PubMed
52.
Hirono S, Shimizu Y, Ohtsuka T et al (2020) Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm (IPMN) of the pancreas; a multicentre, retrospective study of 1074 IPMN patients by the Japan Pancreas Society. J Gastroenterol 55:86–99PubMed
53.
Crippa S, Pergolini I, Rubini C et al (2016) Risk of misdiagnosis and overtreatment in patients with main pancreatic duct dilatation and suspected combined/main-duct intraductal papillary mucinous neoplasms. Surgery 159:1041–1049PubMed
54.
Tanaka M, Fernández-Del Castillo C, Kamisawa T et al (2017) Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 17:738–753PubMed
55.
European Study Group on Cystic Tumours of the Pancreas (2018) European evidence-based guidelines on pancreatic cystic neoplasms. Gut 67:789–804
56.
Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms, Buscarini E, Pezzilli R, Cannizzaro R et al (2014) Italian consensus guidelines for the diagnostic work-up and follow-up of cystic pancreatic neoplasms. Dig Liver Dis 46:479–493
57.
Schmidt CM, White PB, Waters JA et al (2007) Intraductal papillary mucinous neoplasms: predictors of malignant andinvasive pathology. Ann Surg 246:644–514PubMed
58.
Waters JA, Schmidt CM, Pinchot JW et al (2008) CT vs MRCP: optimal classification of IPMN type and extent. J Gastrointest Surg 12:101e9
59.
Rodriguez JR, Salvia R, Crippa S et al (2007) Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 133:72–79PubMed
60.
Fritz S, Schirren M, Klauss M et al (2012) Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas. Surgery 152(3 Suppl 1):S74e80
61.
Pelaez-Luna M, Chari ST, Smyrk TC et al (2007) Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy? A study of 147 patients. Am J Gastroenterol 102:1759–1764PubMed
62.
Rodriguez JR, Salvia R, Crippa S et al (2007) Branch-duct in-traductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 133:72–79PubMed
63.
Schmidt CM, White PB, Waters JA et al (2007) Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg 246:644–651PubMed
64.
Salvia R, Fernández-del Castillo C, Bassi C et al (2004) Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival follow-ing resection. Ann Surg 239:678–685PubMedPubMedCentral
65.
Salvia R, Partelli S, Crippa S et al (2009) Intraductal papillary mucinous neoplasms of the pancreas with multifocal involvement of branch ducts. Am J Surg 198:709–714PubMed
66.
Uehara H, Nakaizumi A, Ishikawa O et al (2008) Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut 57:1561–1565PubMed
67.
Tanno S, Nakano Y, Sugiyama Y et al (2010) Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasm. Pancreatology 10:173–178PubMed
68.
Ito T, Doi R, Yoshizawa A et al (2011) The distribution of atypical epithelium in main-duct type intraductal papillary mucinous neoplasms of the pancreas. J Hepatobiliary Pancreat Sci 18:241–249PubMed
69.
Watanabe Y, Nishihara K, Niina Y et al (2016) Validity of the management strategy for intraductal papillary mucinous neoplasm advocated by the international consensus guidelines 2012: a retrospective review. Surg Today 46:1045–1052PubMed
70.
He J, Cameron JL, Ahuja N et al (2013) Is it necessary to follow patients after resection of a benign pancreatic intraductal papillary mucinous neoplasm? J Am Coll Surg 216:657–665PubMedPubMedCentral
71.
Tamura K, Ohtsuka T, Ideno N et al (2014) Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review. Ann Surg 259:360–368PubMed
72.
Nell S, Verkooijen HM, Pieterman CRC et al (2018) Management of MEN1 related nonfunctioning pancreatic NETs—a shifting paradigm: results From the DutchMEN1 Study Group. Ann Surg 267:1155–1160PubMed
73.
Fahmy JN, Varsanik MA, Hubbs D et al (2021) Pancreatic neuroendocrine tumours: surgical outcomes and survival analysis. Am J Surg 221:529–533PubMed
74.
Falconi M, Eriksson B, Kaltsas G et al (2016) ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumours and non-functional pancreatic neuroendocrine tumours. Neuroendocrinology 103:153–171PubMed
75.
Howe JR, Merchant NB, Conrad C et al (2020) The North American Neuroendocrine Tumour Society consensus paper on the surgical. Pancreas 49:1–33PubMedPubMedCentral
76.
Pavel M, Öberg K, Falconi M et al (2020) Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 31:844–860PubMed
77.
78.
Di Franco G, Gianardi D, Palmeri M et al (2020) Pancreatic resections for metastases: a twenty-year experience from a tertiary care centre. Eur J Surg Oncol 46:825–831PubMed
79.
Huang Q, Zhou H, Liu C et al (2019) Resection for metastatic tumours in the pancreas: a single-centre experience and systematic review. Ann Surg Oncol 26:1649–1656PubMed
80.
Jaen-Torrejimeno I, Rojas-Holguín A, López-Guerra D et al (2020) Pancreatic resection for metastatic renal cell carcinoma. A systematic review. HPB (Oxford) 22:479–486
81.
82.
Tanis PJ, van der Gaag NA, Busch OR et al (2009) Systematic review of pancreatic surgery for metastatic renal cell carcinoma. Br J Surg 96:579–592PubMed
83.
Untch BR, Allen PJ (2014) Pancreatic metastasectomy: the Memorial Sloan-Ketteringexperience and a review of the literature. J Surg Oncol 109:28e
84.
Adler H, Redmond CE, Heneghan HM et al (2014) Pancreatectomy for metastatic disease: a systematic review. Eur J Surg Oncol 40:379e
85.
Kwak BJ, Kim SC, Song KB, Lee JH, Hwang DW, Park KM, Lee YL (2014) Prognostic factors associated with early mortality after surgical resection for pancreatic adenocarcinoma. Korean J Hepatobiliary Pancreat Surg 18:138–146PubMedPubMedCentral
Metadaten
Titel
Contemporary indications for upfront total pancreatectomy
verfasst von
Riccardo Casadei
Claudio Ricci
Carlo Ingaldi
Laura Alberici
Francesco Minni
Publikationsdatum
14.08.2021
Verlag
Springer International Publishing
Erschienen in
Updates in Surgery / Ausgabe 4/2021
Print ISSN: 2038-131X
Elektronische ISSN: 2038-3312
DOI
https://doi.org/10.1007/s13304-021-01145-w

Weitere Artikel der Ausgabe 4/2021

Updates in Surgery 4/2021 Zur Ausgabe

Original Article

Clinical relevant pancreatic fistula after pancreatoduodenectomy: when negative amylase levels tell the truth

Letter to the Editor

Liver transplantation for unresectable intrahepatic cholangiocarcinoma: an Italian experience

Original Article

The extent of colorectal resection and short-term outcomes in patients with ulcerative colitis

Correction

Correction to: Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic. The SICE CLOUD19 Study

Original Article

Mini-laparoscopic adrenalectomy with transgastric specimen extraction

Review Article

Meta-analysis of mesh-plug repair and Lichtenstein repair in the treatment of primary inguinal hernia

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.